Amiko
Amiko provides hardware-enabled, AI-powered digital medicines. Its first product, Respiro, a digital medicine platform that combines connected inhaler sensors, apps, and data analytics to upgrade respiratory care, has been used in clinical studies and more than 30 commercial programmes across Europe.
Amiko is an AI and advanced data analytics company that provides Respiro, a digital medicine platform that combines connected inhaler sensors, apps, and data analytics to upgrade respiratory care. Respiro is a certified medical device and has been used in clinical studies and more than 30 commercial programmes across Europe. The system delivered consistent improvements in treatment adherence and outcomes: 37% increase in medication adherence, 42% improvement in optimal inhaler technique, and a 67% reduction in reliever medication use. Amiko serves patients, healthcare providers and pharmaceutical companies. The company is ISO 13485:2016 certified and has locations in the UK and Italy.
Articles by Amiko
